ARS Pharmaceuticals has announced the availability of neffy (epinephrine nasal spray) 1mg in the US, providing a new option ...

Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.

An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

LTR Pharma (ASX:LTP) has joined forces with Strategic Drug Solutions to developed a nasal spray to treat oesophageal motility ...

The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal spray, Valtoco, for the short-term treatment of acute repetitive seizures, also referred to as seizure clusters ...

Approval is based on results from the Phase III ASCEND trial, in which patients using the powder achieved freedom from pain ...

When Samuel Hockey's doctor suggested he try using a form of ketamine to treat his depression, he was curious."I sort of thought, 'This is just a party drug that I've witnessed friends and people take ...

For five years, the clinical-stage pharmaceutical company has developed Enbumyst, a nasal spray intended to remove excess ...

The US Food and Drug Administration (FDA) has approved Atzumi, a 5.2 mg dihydroergotamine (DHE) nasal powder, for the acute ...

Montgomery County is attributing a dramatic decline in drug deaths to efforts to prevent them, including availability of a ...